J Kozłowski

602 total citations
47 papers, 405 citations indexed

About

J Kozłowski is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, J Kozłowski has authored 47 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 19 papers in Internal Medicine and 6 papers in Epidemiology. Recurrent topics in J Kozłowski's work include Atrial Fibrillation Management and Outcomes (27 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). J Kozłowski is often cited by papers focused on Atrial Fibrillation Management and Outcomes (27 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). J Kozłowski collaborates with scholars based in United States and Brazil. J Kozłowski's co-authors include Scott Kaatz, Brian Haymart, Eva Kline‐Rogers, James B. Froehlich, Geoffrey D. Barnes, Gregory D Krol, Xiaokui Gu, Steve Almany, Suman L. Sood and Jordan K. Schaefer and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

J Kozłowski

39 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Kozłowski United States	13	317	157	58	39	37	47	405
Niccolò Bonini Italy	15	537 1.7×	52 0.3×	56 1.0×	77 2.0×	48 1.3×	48	627
Eric Neuhart France	7	426 1.3×	285 1.8×	128 2.2×	32 0.8×	14 0.4×	13	525
Keitaro Senoo Japan	16	714 2.3×	191 1.2×	35 0.6×	123 3.2×	57 1.5×	49	794
Ewa Mirek-Bryniarska Poland	13	287 0.9×	182 1.2×	57 1.0×	39 1.0×	39 1.1×	29	360
Robert J. Goldberg United States	8	327 1.0×	50 0.3×	92 1.6×	81 2.1×	109 2.9×	9	492
Sameer K. Mehta United States	9	428 1.4×	80 0.5×	229 3.9×	74 1.9×	94 2.5×	16	560
W. Amara France	9	420 1.3×	84 0.5×	114 2.0×	33 0.8×	9 0.2×	57	480
David Parra United States	11	159 0.5×	56 0.4×	76 1.3×	21 0.5×	24 0.6×	24	322
S.S. Rathore United States	8	350 1.1×	30 0.2×	106 1.8×	20 0.5×	94 2.5×	19	519
Rikardo Krakover Israel	9	408 1.3×	57 0.4×	170 2.9×	71 1.8×	37 1.0×	11	572

Countries citing papers authored by J Kozłowski

Since Specialization

Citations

This map shows the geographic impact of J Kozłowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kozłowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kozłowski more than expected).

Fields of papers citing papers by J Kozłowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kozłowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kozłowski. The network helps show where J Kozłowski may publish in the future.

Co-authorship network of co-authors of J Kozłowski

This figure shows the co-authorship network connecting the top 25 collaborators of J Kozłowski. A scholar is included among the top collaborators of J Kozłowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kozłowski. J Kozłowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schaefer, Jordan K., Brian Haymart, Scott Kaatz, et al.. (2024). Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study. Research and Practice in Thrombosis and Haemostasis. 8(4). 102449–102449. 2 indexed citations

Haymart, Brian, Xiaokui Gu, Stephanie W. Watts, et al.. (2022). Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin. Journal of Thrombosis and Thrombolysis. 55(1). 141–148. 5 indexed citations

Haymart, Brian, Scott Kaatz, Vinay Shah, et al.. (2022). Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations. Journal of the American Heart Association. 11(21). e025471–e025471. 7 indexed citations

Gu, Xiaokui, Brian Haymart, Geoffrey D. Barnes, et al.. (2022). Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes. Blood Advances. 6(10). 2977–2980. 1 indexed citations

Haymart, Brian, Scott Kaatz, Gregory D Krol, et al.. (2021). Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures. Thrombosis Research. 203. 27–32. 9 indexed citations

Haymart, Brian, Eva Kline‐Rogers, Scott Kaatz, et al.. (2021). Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients. Journal of Pharmacy Practice. 36(3). 542–547. 3 indexed citations

Barnes, Geoffrey D., Yun Li, Xiaokui Gu, et al.. (2020). Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry‐based cohort study. Journal of Thrombosis and Haemostasis. 18(8). 2025–2030. 6 indexed citations

Hughey, Andrew B., Xiaokui Gu, Brian Haymart, et al.. (2018). Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “Real-World” Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials. Journal of Thrombosis and Thrombolysis. 46(3). 316–324. 14 indexed citations

Barnes, Geoffrey D., Brian Haymart, Eva Kline‐Rogers, et al.. (2018). Extended International Normalized Ratio testing intervals for warfarin‐treated patients. Journal of Thrombosis and Haemostasis. 16(7). 1307–1312. 9 indexed citations

10.

Schaefer, Jordan K., Suman L. Sood, Brian Haymart, et al.. (2017). The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease. Blood. 130. 220–220. 1 indexed citations

11.

Schaefer, Jordan K., Suman L. Sood, Brian Haymart, et al.. (2017). Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Advances. 1(26). 2536–2540. 9 indexed citations

12.

Barnes, Geoffrey D., Scott Kaatz, Elizabeth A. Jackson, et al.. (2017). Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics. Implementation Science. 12(1). 87–87. 18 indexed citations

13.

Schaefer, Jordan K., Suman L. Sood, Brian Haymart, et al.. (2016). A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation. Blood. 128(22). 1179–1179. 1 indexed citations

14.

Kozłowski, J, et al.. (2015). Subsequent Pregnancy in a Patient With Spontaneous Coronary Artery Dissection. Journal of Clinical Gynecology and Obstetrics. 4(1). 177–178. 2 indexed citations

15.

Hughey, Andrew B., Geoffrey D. Barnes, Xiaokui Gu, et al.. (2014). WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION: COMPARISON OF PATIENT CHARACTERISTICS AND OUTCOMES OF THE “REAL-WORLD” MICHIGAN ANTICOAGULATION QUALITY IMPROVEMENT INITIATIVE (MAQI2) REGISTRY TO THE RE-LY, ROCKET-AF, AND ARISTOTLE TRIALS. Journal of the American College of Cardiology. 63(12). A418–A418. 2 indexed citations

16.

Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2013). Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 37(2). 171–176. 12 indexed citations

17.

Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2012). Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 35(1). 10–14. 21 indexed citations

18.

Kozłowski, J, Joseph A. Kozlowski, & Dan Schuller. (1988). Poisoning with sustained-release verapamil. The American Journal of Medicine. 85(1). 127–127. 14 indexed citations

19.

Wasfie, Tarik, Paul S. Freed, Melvyn Rubenfire, et al.. (1988). Risks associated with intraaortic balloon pumping in patients with and without diabetes mellitus. The American Journal of Cardiology. 61(8). 558–562. 21 indexed citations

20.

Kozłowski, J, et al.. (1970). [Persistent facial hemihyperhidrosis].. PubMed. 57(5). 661–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact